187 related articles for article (PubMed ID: 37996731)
1. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
[TBL] [Abstract][Full Text] [Related]
2. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
[TBL] [Abstract][Full Text] [Related]
3. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients.
De Lorenzo R; Loré NI; Finardi A; Mandelli A; Cirillo DM; Tresoldi C; Benedetti F; Ciceri F; Rovere-Querini P; Comi G; Filippi M; Manfredi AA; Furlan R
J Neurol; 2021 Dec; 268(12):4436-4442. PubMed ID: 33973106
[TBL] [Abstract][Full Text] [Related]
4. Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes: Findings From the NCAA and Department of Defense CARE Consortium.
McCrea M; Broglio SP; McAllister TW; Gill J; Giza CC; Huber DL; Harezlak J; Cameron KL; Houston MN; McGinty G; Jackson JC; Guskiewicz K; Mihalik J; Brooks MA; Duma S; Rowson S; Nelson LD; Pasquina P; Meier TB; ; Foroud T; Katz BP; Saykin AJ; Campbell DE; Svoboda SJ; Goldman J; DiFiori J
JAMA Netw Open; 2020 Jan; 3(1):e1919771. PubMed ID: 31977061
[TBL] [Abstract][Full Text] [Related]
5. Blood Biomarkers Relate to Cognitive Performance Years after Traumatic Brain Injury in Service Members and Veterans.
Lippa SM; Gill J; Brickell TA; French LM; Lange RT
J Int Neuropsychol Soc; 2021 May; 27(5):508-514. PubMed ID: 33161932
[TBL] [Abstract][Full Text] [Related]
6. Acute Effects of Sport-Related Concussion on Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay.
Asken BM; Yang Z; Xu H; Weber AG; Hayes RL; Bauer RM; DeKosky ST; Jaffee MS; Wang KKW; Clugston JR
J Neurotrauma; 2020 Jul; 37(13):1537-1545. PubMed ID: 32024456
[TBL] [Abstract][Full Text] [Related]
7. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
[TBL] [Abstract][Full Text] [Related]
8. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
[TBL] [Abstract][Full Text] [Related]
9. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
[TBL] [Abstract][Full Text] [Related]
10. Combined GFAP, NFL, Tau, and UCH-L1 panel increases prediction of outcomes in neonatal encephalopathy.
Yang Z; Xu H; Sura L; Arja RD; Patterson RL; Rossignol C; Albayram M; Rajderkar D; Ghosh S; Wang K; Weiss MD
Pediatr Res; 2023 Apr; 93(5):1199-1207. PubMed ID: 35273370
[TBL] [Abstract][Full Text] [Related]
11. Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI.
Gill J; Latour L; Diaz-Arrastia R; Motamedi V; Turtzo C; Shahim P; Mondello S; DeVoto C; Veras E; Hanlon D; Song L; Jeromin A
Neurology; 2018 Oct; 91(15):e1385-e1389. PubMed ID: 30209234
[TBL] [Abstract][Full Text] [Related]
12. [Expression levels of ubiquitin C-terminal hydrolase-L1 and serum glial fibrillary acidic protein and its clinical significance in patients with acute cerebral infarction].
Hu C; Yang X; Mao D; Lou S; Dai Q; Chen J; Cheng X; Wang S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):284-290. PubMed ID: 28364101
[TBL] [Abstract][Full Text] [Related]
13. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke.
Luger S; Jæger HS; Dixon J; Bohmann FO; Schaefer J; Richieri SP; Larsen K; Hov MR; Bache KG; Foerch C;
Neurocrit Care; 2020 Aug; 33(1):39-48. PubMed ID: 32096121
[TBL] [Abstract][Full Text] [Related]
15. A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.
Kocik VI; Dengler BA; Rizzo JA; Ma Moran M; Willis AM; April MD; Schauer SG
Mil Med; 2024 May; 189(5-6):e1374-e1380. PubMed ID: 37995274
[TBL] [Abstract][Full Text] [Related]
16. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
17. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
[TBL] [Abstract][Full Text] [Related]
18. Utility of Acute and Subacute Blood Biomarkers to Assist Diagnosis in CT-Negative Isolated Mild Traumatic Brain Injury.
Reyes J; Spitz G; Major BP; O'Brien WT; Giesler LP; Bain JWP; Xie B; Rosenfeld JV; Law M; Ponsford JL; O'Brien TJ; Shultz SR; Willmott C; Mitra B; McDonald SJ
Neurology; 2023 Nov; 101(20):e1992-e2004. PubMed ID: 37788938
[TBL] [Abstract][Full Text] [Related]
19. Performance of glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) biomarkers in predicting CT scan results and neurological outcomes in children with traumatic brain injury (BRAINI-2 paediatric study): protocol of a European prospective multicentre study.
Lorton F; Lagares A; de la Cruz J; Méjan O; Pavlov V; Sapin V; Poca MA; Lehner M; Biberthaler P; Chauviré-Drouard A; Gras-Le-Guen C; Scherdel P; ;
BMJ Open; 2024 May; 14(5):e083531. PubMed ID: 38754888
[TBL] [Abstract][Full Text] [Related]
20. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
